Cognitio

ARCS Australia
  • ٠٫٠ (٠)
  • طب

Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting

  1. ١٢ مايو

    Dr Daniel Beard, Founder and CSO ShearFlow

    What if you could give a stroke patient more time? That is the question driving Dr Daniel Beard and the team at ShearFlow, a biotech spin-out from the University of Newcastle developed in joint venture with Harvard University. In this episode, ARCS intern Iqra sits down with Daniel to trace a career that has taken him from a fascination with the brain's blood vessels, through a PhD in stroke research, a postdoctoral fellowship at the University of Oxford, and a cold call to one of Harvard's leading scientists that changed the direction of everything. Daniel is a Senior Lecturer at the University of Newcastle and the Chief Scientific Officer of ShearFlow, where his team is developing a nanoparticle therapy that selectively targets collateral blood vessels during a stroke to extend perfusion to at-risk brain tissue. The implications for rural and remote Australia, where patients can face transfers of hundreds of kilometres to reach a comprehensive stroke centre, are significant. In this conversation, Daniel reflects on the role of collaboration in research and commercialisation, the lessons he took from Oxford back to Australia, and what it actually takes to move from scientific founder to company builder. He also shares his perspective on the gap between invention and innovation, and why persistence matters more than resilience. Topics covered include stroke treatment and the tyranny of distance in Australian healthcare, nanoparticle drug delivery and shear stress-sensitive therapeutics, the University of Newcastle and Harvard University joint venture, postdoctoral research at the University of Oxford, the commercialisation journey from academic discovery to spin-out, intellectual property, tech transfer, and building a founding team, and advice for early career researchers considering the path to innovation. Cognitio is the knowledge platform of ARCS Australia, the professional organisation for people working across therapeutics, medtech, and the pharmaceutical sciences. Visit arcs.com.au to learn more about membership and upcoming programs. Guest: Dr Daniel Beard, Senior Lecturer, University of Newcastle; Founder and Chief Scientific Officer, ShearFlow Host: Iqra, ARCS Australia Intern Series: Season 2, Episode 13

    ٢٧ د

  2. ٤ مايو

    AI Basics for Regulatory Professionals: Safe Use, Smart Prompting and Human Accountability

    Artificial intelligence is already reshaping how regulatory professionals work—but with opportunity comes responsibility. In this episode of Cognitio, we bring you key insights from an ARCS webinar led by Kyle from GXP Vigilance, exploring how AI is being used across regulatory affairs, pharmacovigilance and quality environments, and what professionals need to understand to use it safely and effectively. This is not a conversation about hype. It’s about real-world application in regulated environments, where accuracy, accountability and patient safety cannot be compromised. • Why AI adoption is accelerating across the life sciences sector—and what that means for regulatory roles• The biggest risks of using AI, including hallucinations, fabricated citations and data leakage • The critical importance of human accountability in all AI-assisted outputs• Practical guidance on acceptable vs unacceptable uses of AI in regulated settings• How prompt engineering is evolving—and why it’s becoming a core professional skill• The difference between public AI tools and enterprise-grade solutions• What’s coming next in governance, policy and regulatory expectations for AI AI is a powerful tool—but it is not a source of truth. Human oversight remains essential. Regulatory professionals are still the final decision-makers and are accountable for all outputs. Using AI safely requires discipline. This includes avoiding confidential data, validating outputs and understanding the limitations of large language models. Prompting matters. The quality of input directly impacts the reliability of output, making structured prompting an increasingly valuable capability. Governance is coming. Organisations will need clear frameworks, policies and controls as regulatory expectations evolve. As AI becomes embedded in everyday workflows, regulatory professionals must strike a balance between efficiency and compliance. Those who understand both the capabilities and limitations of AI will be better positioned to lead in a rapidly changing environment—one where professionalism, judgement and trust remain central. ARCS Australia is the peak body for life sciences professionals, advancing capability across the sector through education, community and advocacy. 🎧 Follow Cognitio for more conversations shaping the future of the life sciences sector🔗 Learn more at ARCS Australia What you’ll hear in this episodeKey takeawaysWhy this mattersAbout ARCS Australia

    ٣٩ د

  3. ١ مايو

    ARCS Weekly Wrap - 1 May 2026

    This week on Top 3 with Tim, ARCS CEO Dr Tim Boyle shares the biggest updates shaping the ARCS community and Australia’s life sciences sector. In this short update:• Final call for 2026 ARCS Annual Conference early bird registrations• ARCS announces its new partnership with the Australian Institute of Company Directors (AICD) and the upcoming LifeSciences Company Directors Course• Highlights from a huge week of sector engagement, including the sold-out Leadership Summit with MAPA, Melbourne member networking, and the Monash University careers roadshow Tim also looks ahead to International Clinical Trials Day on 20 May, where ARCS will host a free online symposium focused on governance, AI, digital informed consent and the future of clinical trials in Australia. ARCS continues to champion professionalism, capability building and sector-wide connection across the full life sciences ecosystem. Join the conversation. Join ARCS today.

    **ASE.Web.Podcasts.Duration.Minute.two**

  4. ٢٩ أبريل

    Signals to Clinical Evidence

    How do we separate misinformation from meaningful public health signals, and what happens when digital intelligence is combined with clinical evidence? In this episode of Cognitio, we explore how online sentiment, AI-powered surveillance and real-world healthcare data can work together to identify, investigate and validate emerging vaccine safety concerns. Dr Gerardo Luis Dimaguila, Informatics Lead at the Murdoch Children’s Research Institute and Data Innovation Lead at the Centre for Health Analytics, introduces VaxPulse, a digital surveillance learning health system developed since 2021. Using AI, social listening and advanced analytics, VaxPulse monitors vaccine-related concerns and misinformation across online platforms, helping public health professionals detect early warning signs and better understand the information environment shaping vaccine confidence. Aishwarya Shetty, epidemiologist and vaccine safety specialist at the Centre for Health Analytics, then demonstrates how these digital insights can be translated into rigorous epidemiological investigation. Using VaxPulse data identifying menstrual health concerns following COVID-19 vaccination, Aishwarya presents how large-scale GP syndromic surveillance and broader safety datasets were used to validate public concerns, assess risk and strengthen evidence-based communication. Together, this episode explores:• How AI and digital surveillance are reshaping pharmacovigilance• The growing role of social media as an early signal detection tool• How misinformation and genuine public concerns can be distinguished• The integration of digital signals with GP and clinical datasets• Why transparent, evidence-led communication is critical to vaccine trust This episode is essential listening for professionals in pharmacovigilance, vaccine safety, epidemiology, regulatory affairs, public health and digital health innovation. Cognitio is ARCS Australia’s platform for thought leadership, professional development and sector-wide dialogue across the life sciences ecosystem. Join the conversation. Join ARCS today.

    ٢٩ د

  5. ٢٠ أبريل

    S02E10 High Performance, Hidden Challenges

    What does high performance really look like when it’s shaped by lived experience? In this episode of Cognitio, we explore the intersection between professional capability and chronic illness—and how navigating personal health challenges can fundamentally shape resilience, leadership, and perspective in the life sciences sector. Hosted by Anna Megalakakis from ARCS, this conversation brings together Mark Del Borgo from the Department of Pharmacology at Monash University and his PhD student Isabella Simon. Both are not only researchers, but also consumers of the healthcare system—offering a rare and powerful dual perspective from inside the science and the lived experience it ultimately serves. From the realities of diagnosis and long-term treatment, to the unseen pressures of maintaining performance in high-demand roles, this discussion highlights what often sits beneath the surface in our workplaces and research environments. It also raises important questions for the sector:How do we better support high performers managing chronic conditions?What does empathetic leadership look like in practice?And how can lived experience strengthen—not limit—professional contribution? This is a conversation about resilience, but also about understanding. About the human side of science, and the importance of creating environments where people can perform at their best—because they are supported, not despite their challenges. Living and working with chronic illness in life sciencesThe impact of diagnosis on career direction and ambitionNavigating research, academia, and health simultaneouslyEmpathy, leadership, and building high-performing teamsThe role of lived experience in shaping better science and outcomesAnna Megalakakis – ARCSMark Del Borgo – Department of Pharmacology, Monash UniversityIsabella Simon – PhD Candidate, PharmacologyARCS Australia is the peak body for the life sciences sector, supporting professionals across the full product lifecycle through education, professional development, and community. Key Topics CoveredFeatured in this EpisodeAbout ARCS

    ٤٤ د

  6. ١٣ أبريل

    Teams First: Cultivating Resilient Leaders in Competitive Environments

    What can elite sport teach us about leadership in the workplace? In this episode of the Cognitio Podcast, Tim Boyle sits down with Tomek Szklarski, Head Coach of the Australian National Handball Team, to explore how high-performance sporting environments develop resilient leaders, build trust under pressure, and create cultures where teams thrive. Drawing on his experience as both a professional athlete and national coach, Tomek shares practical lessons from elite team sport that translate directly into leadership, management and team development within professional environments. Together, Tim and Tomek discuss: Why resilience matters more than talent in sustained high-performance environmentsThe transition from peer leadership to formal leadershipHow trust is built, broken and rebuilt under pressureWhy great leaders create capability rather than dependencyThe role of vulnerability and self-awareness in leadershipPractical strategies for developing resilience in yourself and othersWhether you lead a team, manage stakeholders, or are looking to strengthen your own professional resilience, this episode offers valuable insights into what it takes to lead when the pressure is on. Tomek Szklarski is Head Coach of the Australian National Handball Team and a former professional European handball player. He has represented Sydney University, New South Wales and Australia at elite levels of competition, and has played a key role in developing handball talent nationally. Tomek brings a unique perspective on leadership shaped by years of experience as both a player and coach in high-performance sporting environments. About the Guest

    ٣٩ د

  7. ٣١ مارس

    Designing with, not for: The Power of Patient Co-Creation

    What does it really mean to design healthcare with patients? In this episode of the Cognitio Podcast, Georghien Wiley, ARCS Convener for the Patient Engagement Interest Area, leads a powerful and deeply personal discussion on patient co-creation. Through real-world experiences, this episode explores the realities of navigating the healthcare system in Australia, particularly for patients and carers in regional settings. From access challenges and fragmented care to the often-overlooked role of carers, the conversation highlights critical gaps between system design and lived experience. It also reframes a key idea for the life sciences sector:Lived experience is not supplementary to evidence. It is a form of expertise that should shape how we design services, clinical trials and patient support programs. Key themes explored include:• The impact of fragmented and uncoordinated care• The hidden burden and invisibility of carers• Health literacy and communication challenges• The importance of trust, equity and inclusion in co-design• Moving beyond tokenistic engagement to meaningful partnership This episode is essential listening for professionals across clinical research, regulatory affairs, medical affairs, pharmacovigilance and market access who are looking to embed patient-centred approaches into their work.

    ٣٠ د

  8. ٢٣ مارس

    Reimbursement Pathways and Patient Access for Cell and Gene Therapies in Australia

    Cell and gene therapies such as CAR-T are transforming modern medicine, offering new treatment options for cancers and rare diseases. But getting these breakthrough therapies to patients is not straightforward. In this episode of the Cognitio Podcast, Warwick Shaw from Johnson & Johnson explores how advanced therapies move from regulatory approval to reimbursement in Australia. The discussion examines the role of the Medical Services Advisory Committee (MSAC), the National Health Reform Agreement, and the complex coordination between federal and state governments that influences patient access. The conversation also highlights the growing pipeline of cell and gene therapies, the use of outcomes-based reimbursement models, and the policy changes needed to ensure Australian patients can access these life-changing treatments sooner.

    ٤٠ د
مشاهدة الكل (٥٧)

مقطع ترويجي

حول

Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting

المعلومات

  • صناع العمل
    ARCS Australia
  • سنوات النشاط
    ٢٠٢٥ - ٢٠٢٦
  • الحلقات
    ٥٧
  • التقييم
    ملائم
  • حقوق النشر
    © ARCS Australia
  • موقع البرنامج على الويب
    Cognitio